Loading...
Home/RESEARCH 2020
RESEARCH 20202020-06-19T09:27:42+10:00

THE RESEARCH

The survival of children diagnosed with cancer has dramatically improved over the last 10 years. However, for children diagnosed with diffuse intrinsic pontine glioma (DIPG), a form of diffuse midline glioma (DMG), there are no effective pharmacological or immunological treatments available; median survival remains less than 10 months. In Australia, 101 children under the age of 15 die from cancer each year. Although incidence is seemingly rare, DMG including DIPG are responsible for 25% of these deaths.

Until Josie’s diagnosis, Matt’s research was focused on blood cancers, plus breast and colon cancers to a lesser degree. His research expertise saw him secure not one, but two, Early Career Fellowships via Cancer Institute NSW (2014-2016 and 2017-2019). Of such high quality was his work throughout, he was awarded the NSW Premier’s Award for Outstanding Research Fellow in 2019. In addition to the sound scientific research this award highlights, it is also given to those who actively engage with lay and scientific audiences, advocating scientific research and the development of community and industry linkage. Connecting with donors big and small Matt’s gracious receipt of a donation to RUN DIPG via Newcastle Permanent’s annual staff’s charitable donation scheme.

If you would like to organise a similar donation program through your employer or place of business, email hello@rundipg.org. 

2020 FUNDING PRIORITIES

We also aim to support the purchase and development of world-leading infrastructure to enhance and expedite research outcomes, and to assist in moving these treatment strategies into the clinic. A significant challenge faced by Australian families fighting DIPG/DMG is the lack of available clinical trials; the Cancer Signalling Research Group, with the support of RUN DIPG, are dedicated to identifying and initiating much needed clinical trial protocols and fast-tracking these all the way along the research-to-clinic pipeline.

Specific Funding Priorities in 2020

  • Ionising radiation equipment to test strategies to improve standard of care radiotherapy – $300,000
  • Robotics equipment to test improved drug targets – $250,000
  • Support of clinical trials $100,000/pa
  • Establishment of a three year RUN DIPG International Postdoctoral Research Fellowship – $200,000/pa
  • Scholarships to support the best and brightest junior researcher $105,000/pa
  • Project support to improve standard of care treatment $100,000

Donate now

LIVE RESEARCH FEED

Updates from the research team

RESEARCH FUNDING ANNOUNCED!

Studying genome, proteome and phosphoproteome,@MattDun17 and #DUNLAB are looking to classify #DIPG tumours based on the signalling pathways they use to grow.

http://RUNDIPG.org/2021/05/04/dipg-research-at-the-university-of-newcastle-funded-by-rundipg-in-2021

#BrainCancerAwarenessMonth
#DIPGResearch
@UON_research

#BrainCancerAwarenessMonth
5 year survival rate for #BRAINcancer in Australia is 22%.

For breast cancer, it is 91%.

RUN DIPG are committed to supporting the much needed research required to improve survival for brain cancer patients.

#DIPG #DMG
#DIPGResearch

Special delivery!! These legends were in charge of delivering the precious locks of hair from the #CalvaryMaterRadiationOncology ladies, raising $46k with their big shave! They’ll be used to make wigs for patients with cancer or alopecia 💁🏻‍♀️💁🏼‍♀️💁🏽‍♀️💁‍♀️💁🏻‍♀️
#DIPGResearch
#DIPG #DMG

The fantastic five from #CalvaryMaterRadiationOncology are under scissors as we speak!! 💁‍♀️
$41.5k raised, a super effort by five super women 🦸‍♀️
Check out the live feed here!!
#DIPG #DMG
#DIPGResearch https://www.youtube.com/watch?v=TG3RjGcjOcU

Not one, but FIVE staff from #CalvaryMaterRadiationOncology are shaving their locks in the name of #DIPGResearch.
Add to their $34k effort via http://Rundipg.raisely.com/t/radonc or see the shave go down at @TheBennettHotel tomorrow, 6pm!

Load More...
OUR ADDRESS

PO Box 110
St Leonards NSW 1590

CONTACT US

E | hello@rundipg.org

CONNECT WITH US
Go to Top